Connect with us

Press Release

From Wall Street to the World: How 9M AI Is Building the Future of Intelligent Investing

Published

on

New York, US, 2nd May 2025, ZEX PR WIREIn an era where algorithms write headlines and bots mimic behavior, one company is training machines not just to learn — but to invest. Founded in Manhattan and backed by a team of Wall Street veterans and AI researchers from Columbia University, 9M AI is quietly building one of the most ambitious financial systems of the decade: a fully autonomous investment infrastructure that thinks, acts, and evolves — like a human fund manager, but with silicon logic and no sleep cycle.

Its promise is simple and sweeping:

“An AI that knows how to grow your money.”

But behind the tagline lies a methodical, multi-year journey that blends academic rigor, financial realism, and product execution — with its sights set not just on beating the market, but on rewriting the architecture of how asset management works.

Born From Frustration. Built for Everyone.

9M’s origin story reads like a rebellion from within. In 2021, a group of former Goldman Sachs engineers, Columbia AI scientists, and quant traders left high-paying posts in Midtown to start over — in a downtown WeWork. Their frustration? A system designed to serve the few, not the many.

Their mission?

To rebuild access to wealth by engineering Wall Street-grade intelligence that anyone — not just institutions — can use.

It wasn’t just an idea. It was a deliberate plan.
That same year, they began developing NovaMind™, a proprietary AI engine designed to emulate human-like investment judgment. Built with reinforcement learning, natural language processing, and causal inference, the engine didn’t just assist—it made decisions. Complete ones: from strategy creation to risk management to trade execution.

From Model to Market: A Proof-Driven Ascent

In 2022, NovaMind™ made its debut at the “AI Finance Future Forum” in the U.S., drawing attention for its full-stack automation and semantic market interpretation. By 2023, the company had partnered with a U.S. SEC-registered advisory firm for a live market simulation under strict constraints: 8% max drawdown, 6 months, real capital. The results: an average monthly return of 11.2%, with zero manual intervention.

What began as a lab prototype now had real teeth — and real traction.

2024: The Platform Becomes the Product

This year, 9M formally launched the 9M Intelligent Financial System — a next-gen quant architecture powered by nine proprietary AI trading models. The system blends machine learning, large language models, a full-stack execution engine, and blockchain infrastructure, running 24/7 across both traditional and digital asset markets.

What’s unique is not just the tech stack, but the user experience:

  • Real-time earnings display 
  • On-chain verification 
  • Public performance leaderboard 
  • A “simulated AI advisor” interface 
  • One-click cryptographic income statements

The fund structure — built on a triad of strategy pool, capital pool, and reward model — is transparent by design and scalable by intent.

“This isn’t a robo-advisor,” Chris, the CEO of 9M notes. “It’s a system that manages itself — and grows with the user.”

2025–2026: Compliance, Scale, and a Path to Nasdaq

9M isn’t just coding. It’s complying.
The company has completed MSB and NFA registration in the U.S., and has entered the STO regulatory pipeline. Applications are underway in Singapore, Hong Kong, and Canada, with eyes on an eventual Nasdaq main board listing.

By 2026, the company aims to:

  • Surpass $500 million AUM across 60+ markets 
  • Launch three flagship AI funds with tailored risk profiles 
  • Operate a fully regulated global infrastructure

All of this, while holding fast to its core principle: technology should be transparent, traceable, and built to last.

Why It Matters

In an age of AI abundance and fintech noise, 9M’s discipline stands out. It’s not chasing trends. It’s building infrastructure — slowly, visibly, and with conviction.

Where others pitch dashboards, 9M delivers decisions.
Where others sell analytics, 9M automates action.
Where others offer tools, 9M offers a co-pilot — one that doesn’t blink.

“We don’t predict markets,” says the product team. “We train AI to understand them.”

Final Word: AI That Grows With You

For a generation of investors raised on volatility, screen fatigue, and overchoice, 9M’s proposition is both radical and refreshingly simple:
Let the system do the work. Let intelligence compound. Let money grow — without guessing.

Whether it succeeds on a global scale remains to be seen. But if 9M gets it right, the future of investing won’t be human-led.
It’ll be AI-native.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dubai Electronic Security Center to Showcase Cybersecurity Initiatives at GISEC 2025 as Official Government Partner

Published

on

  • DESC will highlight its role in advancing Dubai’s cybersecurity ecosystem and strengthening Dubai’s digital infrastructure
  • The Center will showcase strategic initiatives designed to empower the next generation of cybersecurity talent 
  • H.E. Al Shaibani: “We are committed to strengthening the cybersecurity ecosystem and building strategic partnerships across the public and private sectors.”

Dubai, UAE, 3rd May 2025, ZEX PR WIRE, The Dubai Electronic Security Center (DESC) is set to participate as the official government cybersecurity partner for the eighth consecutive year in the 14th edition of the Gulf Information Security Expo and Conference (GISEC Global 2025), taking place from May 6-8 at the Dubai World Trade Centre. 

The Center’s participation in GISEC Global 2025, which gathers over 25,000 cybersecurity professionals representing more than 160 countries, aligns with its strategic objectives aimed at advancing the Dubai Cyber Security Strategy and reinforcing Dubai’s position as one of the world’s digitally safest cities. This participation reflects the Center’s commitment to safeguarding digital infrastructure, fostering innovation, enhancing cyber resilience, and promoting robust cooperation at both the local and international levels.

During the three-day event, DESC will spotlight a number of key initiatives, including the “Dubai Cyber Challenge”, an exclusive competitive simulation designed to enhance the cyber readiness of Dubai government entities, and the “School of Cyber Defense” CTF competition, which attracted registrations from over 300 university students, engaging them in technical challenges and hands-on training. These programs form a key part of DESC’s ongoing efforts to build a pipeline of skilled cybersecurity professionals equipped to navigate evolving digital threats.

H.E. Yousuf Hamad Al Shaibani, CEO of the Dubai Electronic Security Center, commented:
“DESC’s participation in GISEC Global 2025 reflects our steadfast commitment to securing Dubai’s digital future through proactive cybersecurity measures, innovation-driven initiatives, and an integrated ecosystem that fosters collaboration by building partnerships across public and private sectors. GISEC continues to serve as a dynamic platform where industry leaders, experts, and innovators come together to shape the future of cybersecurity.”

“GISEC 2025 provides a critical platform for strategic engagement with global cybersecurity innovators, allowing us to gain insights into emerging technologies and anticipate future threats. These interactions directly support our efforts to create forward-looking policies, develop advanced cyber solutions, and empower national talent to lead in this field. Through such initiatives, we continue to strengthen Dubai’s position as a global hub for cybersecurity excellence and digital innovation,” Al Shaibani added. 

DESC experts will also take part in high-level panel discussions addressing key challenges and emerging trends in the cybersecurity landscape. The Center will also formalize strategic partnerships and Memorandums of Understanding (MoUs), aimed at enhancing cross-sector collaboration and strengthening national efforts to secure the cyber space.

Visitors to GISEC Global 2025 are invited to explore DESC’s initiatives at Stand A80 in Hall 7, where DESC will showcase its latest projects, including future-ready cybersecurity guidelines and certification programs designed to keep pace with the evolving digital landscape and strengthen national capabilities. The stand will also serve as a unique opportunity for attendees to engage with DESC’s experts and explore opportunities for joint collaboration.

Secure your pass and learn more: GISEC GLOBAL | The World’s Leading Cyber Security Exhibition | 6 – 8 May 2025

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care

Published

on

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

  • Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
  • Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
  • Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
  • Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
  • Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care

Published

on

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

  • Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
  • Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
  • Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
  • Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
  • Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST